Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance

British Journal of Sports Medicine

Volumn 45, Issue 2, 2011, Pages 147-149

  Santiago, Catalina ^a   Ruiz, Jonatan R ^b   Buxens, Amaya ^c   Artieda, Marta ^c   Arteta, David ^c   González Freire, Marta ^a   Rodríguez Romo, Gabriel ^d   Altmäe, Signe ^e   Lao, José I ^f   Gómez Gallego, Félix ^a   Lucia, Alejandro ^a  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c IMG Pharma Biotech S L Parque Tecnologico de Zamudio   (Spain)

^d UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f Preventia Genetics   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRB3 PROTEIN, HUMAN; BETA 3 ADRENERGIC RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ATHLETIC PERFORMANCE; CASE CONTROL STUDY; ENDURANCE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; PHYSIOLOGY;

ADOLESCENT; ADULT; ATHLETIC PERFORMANCE; CASE-CONTROL STUDIES; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; PHYSICAL ENDURANCE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-3; YOUNG ADULT;

EID: 79551502591     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsm.2009.061366     Document Type: Article

References (25)

1. Defoor J, Martens K, Zielinska D, et al. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease. Eur Heart J 2006;27:808-16.
2. Wagoner LE, Craft LL, Zengel P, et al. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 2002;144:840-6.
3. Dallongeville J, Helbecque N, Cottel D, et al. The Gly16→Arg16 and Gln27→Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab 2003;88:4862-6.
4. Snyder EM, Beck KC, Dietz NM, et al. Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans. J Physiol 2006;571:121-30.
5. Wagoner LE, Craft LL, Singh B, et al. Polymorphisms of the beta (2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 2000;86:834-40.
6. Wolfarth B, Rankinen T, Mühlbauer S, et al. Association between a beta2-adrenergic receptor polymorphism and elite endurance performance. Metabolism 2007;56:1649-51.
7. McCole SD, Shuldiner AR, Brown MD, et al. Beta2-and beta3-adrenergic receptor polymorphisms and exercise hemodynamics in postmenopausal women. J Appl Physiol 2004;96:526-30.
8. Moore GE, Shuldiner AR, Zmuda JM, et al. Obesity gene variant and elite endurance performance. Metabolism 2001;50:1391-2.
9. Strosberg AD. Structure and function of the beta 3-adrenergic receptor. Annu Rev Pharmacol Toxicol 1997;37:421-50.
10. Kurokawa N, Young EH, Oka Y, et al. The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals. Int J Obes (Lond) 2008;32:1240-9.
11. Pacanowski MA, Zineh I, Li H, et al. Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. J Transl Med 2008;6:11.
12. Piétri-Rouxel F, St John Manning B, Gros J, et al. The biochemical effect of the naturally occurring Trp64→Arg mutation on human beta3-adrenoceptor activity. Eur J Biochem 1997;247:1174-9.
13. Clément K, Vaisse C, Manning BS, et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:352-4.
14. Terra SG, McGorray SP, Wu R, et al. Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study. Int J Obes (Lond) 2005;29:746-54.
15. de Luis DA, Gonzalez Sagrado M, Aller R, et al. Influence of the Trp64Arg polymorphism in the beta 3 adrenoreceptor gene on insulin resistance, adipocytokine response, and weight loss secondary to lifestyle modification in obese patients. Eur J Intern Med 2007;18:587-92.
16. Bray MS, Hagberg JM, Pérusse L, et al. The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc 2009;41:35-73.
17. Gauthier C, Tavernier G, Charpentier F, et al. Functional beta3-adrenoceptor in the human heart. J Clin Invest 1996;98:556-62.
18. Rozec B, Gauthier C. beta3-Adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 2006;111:652-73.
19. Moniotte S, Kobzik L, Feron O, et al. Upregulation of beta (3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 2001;103:1649-55.
20. Kitamura T, Onishi K, Dohi K, et al. The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart. J Cardiovasc Pharmacol 2000;35:786-90.
21. Dessy C, Moniotte S, Ghisdal P, et al. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation 2004;110:948-54.
22. Chanock SJ, Manolio T, Boehnke M, et al; NCI-NHGRI Working Group on Replication in Association Studies. Replicating genotype-phenotype associations. Nature 2007;447:655-60.
23. Tejedor D, Castillo S, Mozas P, et al; Spanish FH Group. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 2005;51:1137-44.
24. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
25. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 2007;27:363-88.